Journal of Computer-Aided Molecular Design

, Volume 14, Issue 2, pp 135–146

Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogs and their incorporation into a pharmacophore model

  • Mark Froimowitz
  • Kuo-Ming Wu
  • Jason Rodrigo
  • Clifford George
Article

Abstract

Molecular mechanics calculations using MM3-92 and ab initio quantum mechanical calculations using SPARTAN 5.0 were performed on the structurally similar PCP and BTCP, in which only the latter has a cocaine-like pharmacological profile as a dopamine reuptake blocker. Calculations were also performed on BTCP analogs with a methyl group in various positions of the cyclohexane ring. The results for the cis-2-methyl compound, which retains good pharmacological activity, allowed us to determine that an aryl-axial conformer is the biologically active form for at least some of the compounds in this series. However, an aryl-equatorial conformer presents the identical pharmacophore, as shown by superposition of the two conformers. X-ray crystallographic structures were also obtained for BTCP and related compounds with a 2-methyl group on the cyclohexane ring, with reasonable agreement between the computational and experimental results. Superposition studies were performed with two rigid analogs of cocaine which illustrate the optimal orientations of the ammonium hydrogen for monoamine transporters. There is excellent agreement between a `back-bridged' cocaine analog that is optimal as a dopamine reuptake blocker and the previously proposed biologically active conformer of methylphenidate. However, BTCP is found to be a better fit to the `front-bridged' cocaine analog that is optimal for a serotonin reuptake blocker.

ab inito BTCP cocaine conformation crystallography dopamine MM3-92 PCP pharmacophore reuptake blockers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Johnson, K.M. and Jones, S.M., Annu. Rev. Pharmacol. Toxicol., 30 (1990) 707.Google Scholar
  2. 2.
    Vincent, J.P., Kartalovski, B., Geneste, P., Kamenka, J.M. and Lazdunski, M., Proc. Natl. Acad. Sci. USA, 76 (1979) 4678.Google Scholar
  3. 3.
    Vignon, J., Chicheportiche, R., Chicheportiche, M., Kamenka, J.M., Geneste, P. and Lazdunski, M., Brain Res., 280 (1983) 194.Google Scholar
  4. 4.
    Vignon, J., Pinet, V., Cerruti, C., Kamenka, J.-M. and Chicheportiche, R., Eur. J. Pharmacol., 148 (1988) 427.Google Scholar
  5. 5.
    He, X.-S., Raymon, L.P., Mattson, M.V., Eldefrawi, M.E. and de Costa, B.R., J. Med. Chem., 36 (1993) 1188.Google Scholar
  6. 6.
    Ilagouma, M.T., Duterte-Boucher, D., Coderc, E., Vignon, J., Costentin, J. and Kamenka, J.M., Eur. J. Med. Chem., 28 (1993) 377.Google Scholar
  7. 7.
    Chaudieu, I., Vignon, J., Chicheportiche, M., Kamenka, J.-M., Trouiller, G. and Chicheportiche, R., Pharmacol. Biochem. Behav., 32 (1989) 699.Google Scholar
  8. 8.
    Froimowitz, M., J. Comput. Chem., 14 (1993) 934.Google Scholar
  9. 9.
    Froimowitz, M., Patrick, K.S. and Cody, V., Pharm. Res., 12 (1995) 1430.Google Scholar
  10. 10.
    Froimowitz, M., Deutsch, H.M., Shi, Q., Wu, K.-M., Glaser, R., Adin, I., George, C. and Schweri, M.M., Bioorg. Med. Chem. Lett., 7 (1997) 1213.Google Scholar
  11. 11.
    Glaser, R., Adin, I., Shiftan, D., Shi, Q., Deutsch, H.M., George, C., Wu, K.-M. and Froimowitz, M., J. Org. Chem., 63 (1998) 1785.Google Scholar
  12. 12.
    Froimowitz, M. and George, C., J. Chem. Inf. Comput. Sci., 38 (1998) 506.Google Scholar
  13. 13.
    Musso, D.L., Mehta, N.B., Soroko, F.E., Ferris, R.M., Hollingworth, E.B. and Kenney, B., Chirality, 5 (1993) 495.Google Scholar
  14. 14.
    Smith, M.P., George, C. and Kozikowski, A.P., Tetrahedron Lett., 39 (1998) 197.Google Scholar
  15. 15.
    Smith, M.P., Johnson, K.M., Zhang, M., Flippen-Anderson, J.L. and Kozikowski, A.P., J. Am. Chem. Soc., 120 (1998) 9072.Google Scholar
  16. 16.
    Abraham, P., Pitner, J.B., Lewin, A.H., Boja, J.W., Kuhar, M.J. and Carroll, F.I., J. Med. Chem., 35 (1992) 141.Google Scholar
  17. 17.
    Kozikowski, A.P., Saiah, M.K.E., Bergmann, J.S. and Johnson, K.M., J. Med. Chem., 37 (1994) 3440.Google Scholar
  18. 18.
    Madras, B.K., Pristupa, Z.B., Niznik, H.B., Liang, A.Y., Blundell, P., Gonzalez, M.D. and Meltzer, P.C., Synapse, 24 (1996) 340.Google Scholar
  19. 19.
    Meltzer, P.C., Liang, A.Y., Blundell, P., Gonzalez, M.D., Chen, Z., George, C. and Madras, B.K., J. Med. Chem., 40 (1997) 2661.Google Scholar
  20. 20.
    Meltzer, P.C., Blundell, P. and Madras, B.K., Med. Chem. Res., 8 (1998) 12.Google Scholar
  21. 21.
    Meltzer, P.C., Blundell, P., Chen, Z., Yong, Y.F. and Madras, B.K., Bioorg. Med. Chem. Lett., 9 (1999) 857.Google Scholar
  22. 22.
    Quantum Chemistry Program Exchange, Department of Chemistry, Indiana University, Bloomington, IN.Google Scholar
  23. 23.
    Serena Software, Bloomington, IN.Google Scholar
  24. 24.
    Wavefunction Inc., Irvine, CA.Google Scholar
  25. 25.
    Sheldrick, G.M., SHELXTL97 Program for the Refinement of Crystal Structures, University of Göttingen, Germany, 1997.Google Scholar
  26. 26.
    Eaton, T.A., Houk, K.N., Watkins, S.F. and Fronczek, F.R., J. Med. Chem., 26 (1983) 479.Google Scholar
  27. 27.
    Carroll, F.I., Brine, G.A., Boldt, K.G., Mascarella, S.W., Moreland, C.G., Sumner, S.J., Burgess, J.P. and Stejskal, E.O., In Domino, E.F. and Kamenka, J.-M. (Eds.), Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology, NPP Books, Ann Arbor, MI, 1988, pp. 91–106.Google Scholar
  28. 28.
    Kamenka, J.-M. and Chicheportiche, R., In Domino, E.F. and Kamenka, J.-M. (Eds.), Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology, NPP Books, Ann Arbor, MI, 1988, pp. 1–10.Google Scholar
  29. 29.
    Manoharan, M., Eliel, E.L. and Carroll, F.I., Tetrahedron Lett., 24 (1983) 1855.Google Scholar
  30. 30.
    Zenone, F. and Kamenka, J.M., Eur. J. Med. Chem., 26 (1991) 677.Google Scholar
  31. 31.
    Geneste, P., Kamenka, J.-M., Ung, S.N., Herrmann, P., Goudal, R. and Trouiller, G., Eur. J. Med. Chem., 14 (1979) 301.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Mark Froimowitz
    • 1
  • Kuo-Ming Wu
    • 1
  • Jason Rodrigo
    • 1
  • Clifford George
    • 2
  1. 1.Pharm-Eco LaboratoriesLexingtonU.S.A.
  2. 2.Laboratory for the Structure of MatterNaval Research LaboratoryWashingtonU.S.A.

Personalised recommendations